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Genome-wide copy number variationDifferentiation arrest is a hallmark of acute lymphoblastic leukemia (ALL). Among a variety of structural and
chromosomal alterations, especially mutations in genes encoding for regulators of B cell differentiation are
common. The objective of this study was a comprehensive assessment of transcriptional dysregulation and
high-resolution genomic proﬁling of B cell differentiation factors. Here we provide extended materials
and methods regarding transcriptome and genome-wide copy number variation analyses published by
Harder et al. [1]. Our data provide a resource for the identiﬁcation of yet undeﬁned factors that play a putative
functional role in leukemogenesis such as ZNF423, whose aberrant expression interferes with B-cell
differentiation.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-SA license
(http://creativecommons.org/licenses/by-nc-sa/3.0/).cimens
A Affymetrix, human
Array Affymetrix
zed data: SOFT, MINiML, TXT
genome-wide copy number
precursor ALL of childhood
s were obtained with writtenDirect link to deposited data
Deposited data can be found here: http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc=GSE42221 and http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc=GSE42056.
Experimental design, materials and methods
Patient samples
All primary human sampleswere obtained upon approval by Institu-
tional Ethics Boards. Patients were recruited by the COALL multicenter
clinical trial group (Germany) and enrolled in trials COALL 97 and 03.
informed consent of patients' parents or their legal
guardians's Cancer Center, Martinistrasse
fax: +49 40 426051219.
. This is an open access article underFor patient characteristics and clinical data refer to Table 1. Mononucle-
ated cells (MNC) frombonemarrowor peripheral bloodwere processed
by gradient centrifugation (Biocoll separation solution, Biochrom) and
cryopreserved.
Gene expression array
For a comparative matched pair expression analysis, single primary
leukemic cells and normal lymphoblasts were isolated from the same
individual, using a MoFlow Cytomation instrument by CD34, CD10
and CD19 staining. Please note that primary ALL I4 had a blast fraction
of greater than 95% and was included without single cell sort due to
experimental circumstances. Total RNA was isolated from a minimum
of 4 × 103 mononucleated cells. Quality and concentration of isolated
RNAwere determined using anAgilent RNA 6000Nano kit on anAgilent
Bioanalyzer. Total RNA underwent linear ampliﬁcation in a two-step
procedure and was labeled and hybridized to each array according to
the manufacturer's instructions using the small sample protocol.
Human GeneChip U133A arrays (Affymetrix) were then washed using
the Affymetrix Fluidics Station 400 and scanned using a HP GeneArray
scanner. The array image was acquired using the Affymetrix GeneChip
Microarray Suite 5.0. Software. The samples were normalized using
the MAS5 method and scaled to a target value of 100.
Quality control
We used Bioconductor packages (simpleaffy [2] and arrayQuality-
Metrics [3]) to assess the quality of the array experiment. As shown inthe CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).
Table 1
Patient characteristics. M, male; F, female; C-ALL, common ALL; NA, not available.
ID Sex Immuno-phenotype BCR–ABL MLL–AF4 ETV6–RUNX1 Hyper-diploidy ZNF423mRNA expression
6646 M C-ALL 0 NA 0 1 36.23
6787 M preB-ALL NA NA NA 0 17.00
6822 M C-ALL 0 0 1 0 24.97
6845 M C-ALL 0 NA 0 NA 51.38
6869 M C-ALL 0 0 0 1 7.91
6923 M preB-ALL NA NA NA 0 22.20
6924 M C-ALL 0 0 0 0 9.79
6965 F C-ALL 0 0 1 0 19.08
6992 F preB-ALL 0 0 1 NA 18.81
7021 M C-ALL 0 0 1 0 39.56
7065 M C-ALL 0 0 0 0 8.71
7077 M C-ALL 0 0 1 NA 27.48
7115 M C-ALL 0 0 1 0 47.38
7118 M C-ALL 0 0 0 0 20.88
7137 F proB-ALL 0 0 0 0 13.54
7191 F C-ALL 0 0 1 0 69.07
7293 F C-ALL 0 0 1 0 6.52
7360 M C-ALL 0 0 1 0 17.42
7503 M C-ALL 0 0 1 0 27.27
7523 F C-ALL 0 0 1 0 26.80
97L. Harder et al. / Genomics Data 2 (2014) 96–98Fig. 1, samples are affected by slight degradation likely due to the
elaborate cell selection and material isolation procedures followed by
two ampliﬁcation steps. In addition, a slight batch effect can be
observed. Nevertheless, good sample comparability is given, because
the degree of degradation is almost identical across all samples and
the batch effect, which manifests as an overall higher signal intensity
in one group, is readily eliminated during the normalization process.
Basic microarray analysis
The expression data of primary ALL at diagnosis (I1s, I2s, I3s, and
I4; s, sorted cellular material) were independently ﬁltered based on
deﬁned cutoff criteria such as present call, signal intensity (SI) ≥ 20,Fig. 1.Qualitymetrics for gene expression dataset GSE42221. (A) The rate of present calls (%), sc
the simpleaffy package. (B) The dissimilarity matrix of the arrays ahead of normalization sho
background and normalization procedure. The scores displayed in the dissimilarity matrices (bl
They are computed as the mean absolute difference between the array data.increase (I) or decrease call (D), change P value ≤0.003 for I/≥0.997
for D and signal log ratio (SLR) ≥ 0.5849 for I/≤−0.415 for D (equiva-
lent to 1.5× up- or down-regulation), which arose from the comparison
with the corresponding remission material (E1s, E2s, E3s, and E4s) as
control. In all comparisons initial scaling was set to a target signal
of 100. All genes meeting these cutoff criteria were considered to be
differentially expressed, as depicted in the heatmap.
Quantitative real-time PCR
Ahead of high-resolution genomic proﬁling ZNF423 expression
was evaluated by quantitative real time PCR (qPCR) in 200 primary B-
precursor ALL samples. For this purpose RNA isolation was performedaling factors (blue bars) aswell as 3′ to 5′ ratios for ß-ACTIN andGAPDHwere calculated by
ws a batch effect that is linked to hybridization date. (C) This effect is eliminated by the
ue: high similarity, yellow: low similarity) reﬂect the distance between each pair of arrays.
Table 2
Affymetrix SNP array quality metrics.
GEO accession Sample name Contrast QC QC call rate
GSM1031509 ALL 6869 initial 1.00 94.04
GSM1031510 ALL 6845 initial 1.43 94.01
GSM1031511 ALL 6646 initial 1.77 95.33
GSM1031512 ALL 7021 initial 1.24 91.99
GSM1031513 ALL 6923 initial 2.14 95.43
GSM1031514 ALL 7077 initial 2.29 95.2
GSM1031515 ALL 7191 initial 2.04 96.13
GSM1031516 ALL 7115 initial 1.21 91.53
GSM1031517 ALL 7360 initial 2.02 97.15
GSM1031518 ALL 7065 initial 1.93 94.97
GSM1031519 ALL 6965 initial 1.67 95.96
GSM1031520 ALL 7503 initial 2.14 95.47
GSM1031521 ALL 7523 initial 2.18 96.03
GSM1031522 ALL 6992 initial 2.02 96.03
GSM1031523 ALL 6787 initial 2.32 97.25
GSM1031524 ALL 6924 initial 1.68 93.28
GSM1031525 ALL 7137 initial 2.49 97.88
GSM1031526 ALL 6822 initial 2.79 95.57
GSM1031527 ALL 7118 initial 4.26 95.6
GSM1031528 ALL 7293 initial 2.07 97.29
GSM1031529 ALL 6869 remission 1.75 93.81
GSM1031530 ALL 6845 remission 1.21 94.57
GSM1031531 ALL 6646 remission 1.66 94.71
GSM1031532 ALL 7021 remission 1.87 94.11
GSM1031533 ALL 6923 remission 1.95 96.23
GSM1031534 ALL 7077 remission 2.29 95.43
GSM1031535 ALL 7191 remission 1.72 94.08
GSM1031536 ALL 7115 remission 1.98 94.34
GSM1031537 ALL 7360 remission 0 93.58
GSM1031538 ALL 7065 remission 2.62 97.58
GSM1031539 ALL 6965 remission 1.57 94.57
GSM1031540 ALL 7503 remission 1.7 94.61
GSM1031541 ALL 7523 remission 1.97 95.6
GSM1031542 ALL 6992 remission 1.99 95.93
GSM1031543 ALL 6787 remission 2.12 97.32
GSM1031544 ALL 6924 remission 2.17 96.29
GSM1031545 ALL 7137 remission 2.18 96.62
GSM1031546 ALL 6822 remission 2.41 95.9
GSM1031547 ALL 7118 remission 1.91 92.55
GSM1031548 ALL 7293 remission 1.42 94.28
98 L. Harder et al. / Genomics Data 2 (2014) 96–98after TRIZOL lysis (Invitrogen) according tomanufacturer's instructions.
TRIZOL-isolated RNA was reverse transcribed to cDNA by M-MLV
reverse transcriptase for 1 h at 37 °C using random primers (Promega).
qPCR was carried out with SYBR Green I (Roche) according to
manufacturer's instructions using following primers: ZNF423 (NM_
015069.2) fw: 5′-gca gac ctg acg gac cac-3′ and rev-5′-agg cca ccc agg
aga gtt-3′; and beta-2-microglobulin (B2M, NM_004048) fw: 5′-ttc tgg
cct gga ggc tatc-3′ and rev: 5′-tca gga aat ttg act ttc cat tc-3′. Relative
mRNA levels were depicted after normalization to B2M (2−ΔCt*1000)
as a reference gene. For genomic proﬁling ALL samples from 20patients that showed a signiﬁcantly higher ZNF423 expression than he-
matopoietic/lymphopoietic progenitors at various stages of develop-
ment, were selected.
High resolution genomic proﬁling
Genomic DNA was isolated from 20 initial ALL samples and
intraindividually matched mononuclear cells (MNC) from remission
bone marrow using the QIAGEN DNA Blood Mini Kit following the
manufacturer's instructions. Sample preparation, hybridization and
stainingwere performed according to themanufacturer's standard pro-
tocol for Affymetrix Genome-Wide Human SNP 6.0 microarrays. Arrays
were scanned on an Affymetrix 3000 7G GeneChip scanner using the
Affymetrix Command Console Software. Processing of the raw signals
and raw copy-number calculation were performed using the CRMA
(version 2) procedure (Aroma, Affymetrix Package Version 2.0.0)
for R statistical platform (version 2.12.1) according to the Aroma
Affymetrix vignette for paired total copy-number analysis. CBS algo-
rithm (DNA copy package version 1.24.0) was then applied to perform
segmentation. Quality was accessed using the Contrast QC metric
recommended by Affymetrix and displayed in Table 2.
Discussion
In this report we provide an extended description of materials and
methods for two datasets deposited in the GEO database containing
gene expression and high-resolution genomic proﬁling data. The corre-
sponding biologic material was isolated from ﬂuorescence activated
sorted primary leukemic cells (except one case) and normal lympho-
blasts (gene expression data) as well as from 20 initial ALL and
intraindividually matchedMNC from remission bonemarrow (genomic
data). Based on these data we identiﬁed a potentially causative
role for ZNF423 in ALL by its interference with B-cell differentiation
and modulation of Smad1–Smad4 dependent transcription [1]. We
encourage the use of our deposited datasets for further investigation
into mechanistic underpinnings of ALL. We will provide further
information if needed.
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